FLAsia 2026 Unveils New Global Partnerships and Growth Opportunities in Singapore
Franchising & Licensing Asia (FLAsia) returns for its 21st edition from 13 to 15 August 2026, attracting over 7,000 trade visitors and more than 250 exhibiting brands. The event, held at Sands Expo and Convention Centre in Singapore, promises a stronger international focus with new partnerships and expanded collaboration opportunities.
FLAsia 2026 is organized by MP Singapore and presented by the Franchising & Licensing Association (Singapore), marking the first time under a new organizer partnership, described by Mr. Gan Shee Wen, President of the association, as a 'dynamic leap forward'. Jason Ng, Managing Director of MP Group, highlights the goal of connecting brands, partners, and stakeholders to create real business outcomes.
The event features international pavilions and participation from key global markets, boosting its cross-border appeal. Returning elements include the Brand Licensing Village, spotlighting locally developed intellectual property and encouraging partnerships. The Chinese Franchise Conference also returns, reflecting ongoing interest from Chinese brands looking to expand. Attendees can expect curated business sessions, industry discussions, and talent engagement opportunities. Dedicated zones focus on innovation and brand growth, reinforcing FLAsia's role as a key platform for market entry and expansion in Asia.
FLAsia 2026 aims to build on its reputation as a leading business hub for franchising and licensing in the region. With expanded international participation and a renewed organizer partnership, the event is positioned to deliver more networking and growth opportunities for small business ideas and eventbrite users.
Read also:
- Federal Funding Supports Increase in Family Medicine Residency Program, Focusing on Rural Health Developments
- Potential Role of DHA in Shielding the Brain from Saturated Fats?
- Alternative Gentle Retinoid: Exploring Bakuchiol Salicylate for Sensitive Skin
- Hanoi initiates a trial program for rabies control, along with efforts to facilitate the transition from the dog and cat meat trade industry.
